Indication: Epilepsy

A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus

Drug Study

Principal Investigator: Samir Karia, M.D.
Norton Children's Neurology, affiliated with the UofL School of Medicine

Sponsor: Marinus Pharmaceuticals, Inc

Search our entire site.